Unknown

Dataset Information

0

Expanding evidence leads to new pharmacogenomics payer coverage.

ABSTRACT:

SUBMITTER: Empey PE 

PROVIDER: S-EPMC8222707 | biostudies-literature | 2021 May

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Expanding evidence leads to new pharmacogenomics payer coverage.

Empey Philip E PE   Pratt Victoria M VM   Hoffman James M JM   Caudle Kelly E KE   Klein Teri E TE  

Genetics in medicine : official journal of the American College of Medical Genetics 20210224 5

Similar Datasets

Unknown EXAMINING EVIDENCE IN U.S. PAYER COVERAGE POLICIES FOR MULTI-GENE PANELS AND SEQUENCING TESTS.
| S-EPMC5732073 | biostudies-literature
Unknown Payer coverage policies for multigene tests.
| S-EPMC5553867 | biostudies-literature
Unknown Fibrate pharmacogenomics: expanding past the genome.
| S-EPMC7202259 | biostudies-literature
Unknown Private payer coverage policies for ApoE-e4 genetic testing.
| S-EPMC8035237 | biostudies-literature
Unknown Private payer coverage policies for exome sequencing (ES) in pediatric patients: trends over time and analysis of evidence cited.
| S-EPMC6329652 | biostudies-literature
Unknown Availability and payer coverage of BRCA1/2 tests and gene panels.
| S-EPMC4625918 | biostudies-literature
Unknown Is expanding Medicare coverage cost-effective?
| S-EPMC1079833 | biostudies-literature
Unknown The Effect of Intra-articular Hyaluronic Acid Injections and Payer Coverage on Total Knee Arthroplasty Procedures: Evidence From Large US Claims Database.
| S-EPMC9816901 | biostudies-literature
Unknown Use of Real-World Evidence in US Payer Coverage Decision-Making for Next-Generation Sequencing-Based Tests: Challenges, Opportunities, and Potential Solutions.
| S-EPMC7219085 | biostudies-literature
Unknown Real-World Evidence: Bridging Gaps in Evidence to Guide Payer Decisions.
| S-EPMC7895868 | biostudies-literature